Cwm LLC Buys 353 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Cwm LLC increased its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 7.3% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 5,167 shares of the company’s stock after acquiring an additional 353 shares during the period. Cwm LLC’s holdings in Bath & Body Works were worth $223,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. lifted its position in shares of Bath & Body Works by 0.3% during the 3rd quarter. Vanguard Group Inc. now owns 25,689,543 shares of the company’s stock worth $868,307,000 after buying an additional 67,920 shares during the period. Darsana Capital Partners LP bought a new position in shares of Bath & Body Works during the 3rd quarter worth approximately $76,050,000. Charles Schwab Investment Management Inc. lifted its position in shares of Bath & Body Works by 1.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,925,647 shares of the company’s stock worth $65,087,000 after buying an additional 27,627 shares during the period. Alua Capital Management LP lifted its position in shares of Bath & Body Works by 30.2% during the 3rd quarter. Alua Capital Management LP now owns 1,693,200 shares of the company’s stock worth $57,230,000 after buying an additional 392,800 shares during the period. Finally, Earnest Partners LLC lifted its position in shares of Bath & Body Works by 1,055,015.7% during the 3rd quarter. Earnest Partners LLC now owns 1,276,690 shares of the company’s stock worth $43,152,000 after buying an additional 1,276,569 shares during the period. Institutional investors own 95.14% of the company’s stock.

Insider Buying and Selling at Bath & Body Works

In other news, insider Thomas E. Mazurek sold 4,285 shares of the company’s stock in a transaction that occurred on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total value of $209,493.65. Following the transaction, the insider now owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.19% of the company’s stock.

Bath & Body Works Price Performance

Shares of Bath & Body Works stock opened at $45.97 on Friday. Bath & Body Works, Inc. has a one year low of $27.30 and a one year high of $50.34. The firm has a market cap of $10.34 billion, a price-to-earnings ratio of 11.90, a price-to-earnings-growth ratio of 1.42 and a beta of 1.89. The stock’s 50-day moving average is $46.09 and its 200-day moving average is $40.93.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.21. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The business had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.84 billion. During the same quarter in the prior year, the company posted $1.86 earnings per share. Bath & Body Works’s revenue was up .8% on a year-over-year basis. On average, equities analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 8th. Shareholders of record on Friday, February 23rd were paid a $0.20 dividend. The ex-dividend date was Thursday, February 22nd. This represents a $0.80 annualized dividend and a yield of 1.74%. Bath & Body Works’s dividend payout ratio is 20.78%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on BBWI shares. Evercore ISI lifted their price objective on Bath & Body Works from $30.00 to $45.00 and gave the company an “in-line” rating in a research report on Friday, March 1st. Wells Fargo & Company lifted their price objective on Bath & Body Works from $42.00 to $48.00 and gave the company an “equal weight” rating in a research report on Wednesday, April 24th. BMO Capital Markets lifted their price objective on Bath & Body Works from $48.00 to $50.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Piper Sandler lifted their price objective on Bath & Body Works from $44.00 to $45.00 and gave the company a “neutral” rating in a research report on Tuesday, April 9th. Finally, Robert W. Baird boosted their target price on Bath & Body Works from $50.00 to $54.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $46.73.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.